Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0350
-0.0010 (-2.78%)
Jun 19, 2026, 4:10 PM AEST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of 128.03 million as of June 18, 2026. Its market cap has increased by 83.17% in one year.
Market Cap
128.03M
Enterprise Value
121.72M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 12.97M to 128.03M, an increase of 886.93%. That is a compound annual growth rate of 13.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 128.03M | -34.14% |
| Dec 31, 2025 | 194.40M | 148.21% |
| Dec 31, 2024 | 78.32M | 54.29% |
| Dec 29, 2023 | 50.76M | -71.90% |
| Dec 30, 2022 | 180.63M | -36.39% |
| Dec 31, 2021 | 283.98M | 832.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 147.48M |
| Alterity Therapeutics | 125.07M |
| Dimerix | 114.08M |
| Nyrada | 112.68M |
| Island Pharmaceuticals | 109.49M |
| Paradigm Biopharmaceuticals | 94.58M |
| LTR Pharma | 92.71M |
| Arovella Therapeutics | 84.61M |